A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...
RNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.
Persistent viral antigens or remnant SARS-CoV-2 RNA have been implicated in sustaining innate immune activation in a subset of individuals with post-acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback